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Background
Phytochemical analysis of the fruits of Solanum lycocar-
pum, popularly known as “fruit of the wolf”, showed high
concentrations of steroidal alkaloids, such as solasonine
and solamargine which are substances with potential
cytotoxic activity [1]. The cytotoxic activity displayed by
these compounds may be due to presence of sugar moi-
eties (rhamnose). Since there is interaction of glycoalka-
loids with plasma membrane cholesterol leading to loss
of membrane integrity, resulting in alterations in its per-
meability what induces cell death [2]. The aim of this
study was to evaluate the cytotoxicity activity of the gly-
coalkaloids solamargine and solasonine purified from
S. lycocarpum and commercial a-solanine alkaloid from
potato sprout toward cell lines MCF-7 (human breast
adenocarcinoma cell line), B16 (murine skin) and 3T3
(normal mouse embryo fibroblasts) by MTT.
Methods
The cells lines were cultured at 37°C in a humidified
atmosphere containing 5% of CO2 supplemented with
15% fetal bovine serum, using Dulbecco’s modified
Eagle’s medium (Sigma). Penicillin (100 U/mL), strepto-
mycin (100 ug/mL) and ciprofloxacin (100 ug/mL) were
added to the medium to prevent bacterial growth.
A stock solution (10 mg/mL) of glicoalkaloid was pre-
pared in 5% DMSO. Solamargine, Solasonine purified
from S. lycocarpum and alfa-Solanine (Sigma) was
directly diluted in the medium to obtain concentrations
ranging from 57.5 to 5.75 uM. The final concentration of
DMSO was less than 0.5% and it had no negative effects
on the cell lines. Cells were trypsinized (0.15% trypsin
and 0.02% EDTA), counted in a hemocytometer (2.5 x
105cells/well), and incubated in a 96-well plate for 24 h.
After addition of the alkaloid or vehicle dissolved in fresh
medium, the cells were cultured at 37 °C in a 5% CO2
atmosphere for 48 h, and cytotoxicity was analyzed by
the MTT assay. For this purpose, 20 uL MTT/well
(5 mg/mL in Hanks solution) were added to the 96-well
plate, and the assay was incubated for 4 h under the
same conditions. Hereafter, the plates were measured
through 550nm wavelength analysis, using an ELISA
reader. Treatments were compared to negative control
(medium with 0.5% DMSO) and positive controls Doxor-
ubicin (0,258uM) and actinomycin D (0,119uM) [3].
Cytotoxicity was calculated by the formula: percent cyto-
toxicity = (1-[absorbance of experimental wells/absor-
bance of control wells]) × 100%. IC50 values were also
determined. Data were analyzed by the Sisvar software.
Results and conclusion
For the cell line MCF-7 the IC50 of Solamargine, solaso-
nina and a-solanine were 13.55, 14.57 uM and 51.23 uM,
respectively. The 3T3 cell line showed IC50 value of
20.11 uM, 13.47 and 49.79 of Solamargine, solasonina
and a-solanine, respectively. Tested compounds (sola-
margine, solasonina and a-solanine) showed higher cyto-
toxicity to B16 with IC50 values of 34.075, 22.611 and
57.380 uM, respectively. Finally the tested glycoalkaloids
showed pronunciated cytotoxity activity and may be
further explored for the development of potential lead
compounds active against cancer cells.
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